(36) Kasdan TS. Medical Nutrition Therapy for Anaemia. In: Mahan LK, Escott-Stump S, editors. Krause's Food, Nutrition, and Diet Therapy.

Size: px
Start display at page:

Download "(36) Kasdan TS. Medical Nutrition Therapy for Anaemia. In: Mahan LK, Escott-Stump S, editors. Krause's Food, Nutrition, and Diet Therapy."

Transcription

1 Reference List (1) Sherlock S, Dooley J. Diseases of the Liver and Biliary System. 9th ed. Oxford: Blackwell Scientific, (2) Wanless IR. Anatomy, Histology, Embryology, and Developmental Anomalies of the Liver. In: Feldman M FLSM, editor. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Pathophysiology/Diagnosis/Management. (3) Morgan MY. Nutritional Aspects of Liver and Biliary Disease. In: Bircher J BJ-PMNRMRJ, editor. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (4) Stolz A. Liver Physiology and Metabolic Function. In: Feldman M FLSM, editor. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Pathophysiology/Diagnosis/Management. (5) Mizock BA. Nutritional support in hepatic encephalopathy. Nutrition 1999; 15(3): (6) Muller MJ, Pirlich M, Balks HJ, Selberg O. Glucose intolerance in liver cirrhosis: role of hepatic and nonhepatic influences. Eur J Clin Chem Clin Biochem 1994; 32(10): (7) Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM et al. Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 1974; 127(1): (8) Korsten MA, Lieber CS. Nutrition in Pancreatic and Liver Disorders. In: Shils et al., editor. Modern Nutrition in Health and Disease. London: Lea & Febiger, (9) Gerber T, Schomerus H. Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management. Drugs 2000; 60(6): (10) Arroyo V, Gines P, Jimenez W, Rodes J. Renal Dysfunction in Cirrhosis. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (11) Berengeuer M, Wright TL. Viral Hepatitis. (Eds). In: Feldman M, Friedman LS, Sleisenger MH, editors. (12) Gerlich WH, Thomssen R. The Viruses of Hepatitis. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (13) Ryder SD, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system: Acute hepatitis. BMJ 2001; 322(7279): (14) Dusheiko G. Hepatitis B. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (15) Bayless TM. Current Therapy in Gastroenterology and Liver Disease. 4 ed. London: Mosby, (16) Hasse JM, Matarese LE. Medical Nutrition Therapy for Liver, Biliary System, and Exocrine Pancreas Disorders. In: Mahan LK, Escott-Stump S, editors. Krause's Food, Nutrition, & Diet Therapy. London: WB Saunders Company, (17) Popper H. Viral Hepatitis 1. Acute Form. In: Netter FH, editor. The Ciba Collection of Medical Illustrations. Part III. Liver, Biliary Tract and Pancreas. Cincinatti: The Hennegan Company, (18) Leevy CM, Sherlock S, Tygstruo N, Zetterman R. Diseases of the Liver, and Biliary Tract. New York: Raven Press, (19) Piche T, Schneider SM, Tran A, Benzaken S, Rampal P, Hebuterne X. Resting energy expenditure in chronic hepatitis C. J Hepatol 2000; 33(4): (20) Lidofsky SD. Liver transplantation for fulminant hepatic failure. Gastroenterol Clin North Am 1993; 22(2): (21) Wicks C. Nutrition and Liver Disease. In: Payne-James J, Grimble G, Silk D, editors. Artificial Nutrition Support in Clinical Practice. London: Greenwich Medical Media Limited, (22) Walsh K, Alexander G. Alcoholic liver disease. Postgrad Med J 2000; 76(895): (23) Tuyns AJ, Pequignot G. Greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int J Epidemiol 1984; 13(1): (24) Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997; 41(6): (25) Maher JJ. Alcoholic Liver Disease. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Pathophysiology/Diagnosis/Management. London: Saunders, (26) Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995; 346(8981): (27) Yu AS, Keeffe EB. Nonalcoholic fatty liver disease. Rev Gastroenterol Disord 2002; 2(1): (28) Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002; 17 Suppl:S186-S190. (29) Diehl AM, Poordad F. Nonalcoholic Fatty Liver Disease. In: Feldman M, Friedman LS, Sleisenger MH, Pathophysiology/Diagnosis/Management. (30) Zakim D, Boyer T. Hepatology. A Textbook of Liver Disease. 2 ed. London: WB Saunders, (31) Allard JP. Other disease associations with non-alcoholic fatty liver disease (NAFLD). Best Pract Res Clin Gastroenterol 2002; 16(5): (32) Youssef WI, McCullough AJ. Steatohepatitis in obese individuals. Best Pract Res Clin Gastroenterol 2002; 16(5): (33) Cox DW, Roberts EA. Wilson Disease. (Eds). In: Feldman M, Friedman LS, Sleisenger MH, editors. (34) Bacon BR, Britton RS. Hereditary Hemochromatosis. In: Feldman M, Friedman LS, Sleisenger MH, editors. (35) Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991; 90(4):

2 (36) Kasdan TS. Medical Nutrition Therapy for Anaemia. In: Mahan LK, Escott-Stump S, editors. Krause's Food, Nutrition, and Diet Therapy. London: WB Saunders Company, (37) Mihas AA. Cirrhosis and the liver. Postgraduate Med 2001; 109: (38) Erlinger S, Benhamou J-P. Cirrhosis: Clinical Aspects. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (39) Whitney EN, Cataldo C, DeBruyne LK, Rolfes SR. Nutrition for Health and Health Care. 2 ed. London: Wadsworth, (40) Gonzalez-Abraldes J, Garcia-Pagan JC, Bosch J. Nitric oxide and portal hypertension. Metab Brain Dis 2002; 17(4): (41) Witte CL, Witte MH, Dumont AE, Frist J, Cole WR. Lymph protein in hepatic cirrhosis and experimental hepatic and portal venous hypertension. Ann Surg 1968; 168(4): (42) Yablonski ME, Lifson N. Mechanism of production of intestinal secretion by elevated venous pressure. J Clin Invest 1976; 57(4): (43) Davern TJ, Scharschmidt BF. Biochemical Liver Tests. In: Feldman M, Friedman LS, Sleisenger MH, Pathophysiology/Diagnosis/Management. (44) Beckingham IJ, Ryder SD. ABC of diseases of liver, pancreas, and biliary system. Investigation of liver and biliary disease. BMJ 2001; 322(7277): (45) Hegab AM, Luketic VA. Bleeding esophageal varices. How to treat this dreaded complication of portal hypertension. Postgrad Med 2001; 109(2):75-6, 89. (46) Krige JE, Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Portal hypertension-1: varices. BMJ 2001; 322(7282): (47) Luca A, Garcia-Pagan JC, Bosch J, Feu F, Caballeria J, Groszmann RJ et al. Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosis. Gastroenterology 1997; 112(4): (48) Ready JB, Hossack KF, Rector WG, Jr. The effects of ethanol administration on portal pressure and gastroesophageal collateral blood flow in patients with alcoholic cirrhosis. Hepatology 1990; 11(4): (49) Silva G, Fluxa F, Bresky G, Backhouse C, Palma M, Ruiz M et al. Splanchnic and systemic hemodynamics in early abstinence and after ethanol administration in non-cirrhotic alcoholic patients. J Hepatol 1994; 20(4): (50) Sugano S, Kawafune T, Okajima T, Ishii K, Watanabe M, Takamura N. Chronic splanchnic hemodynamic effects of spironolactone with unrestricted sodium diet in patients with compensated cirrhosis. Dig Dis Sci 1998; 43(4): (51) Hawker F. The Liver. London: WB Saunders Co Ltd, (52) Arroyo V, Gines P, Planas R, Rodés. Pathogenesis, Diagnosis, and Treatment of Ascites in Cirrhosis. In: Bircher J, Benhamou J-P, McIntyre N, Rizetto M, Rodés J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press, (53) Magri P, Auletta M, Andreucci M, Somma G, Musone D, Fiorillo M et al. Sodium retention in preascitic stage of cirrhosis. Semin Nephrol 2001; 21(3): (54) Runyon BA. Ascites and Spontaneous Bacterial Peritonitis. In: Feldman M, Friedman LS, Sleisenger MH, Pathophysiology/Diagnosis/Management. (55) Garcia N, Jr., Sanyal AJ. Minimizing ascites. Complication of cirrhosis signals clinical deterioration. Postgrad Med 2001; 109(2): (56) Casafont F, Sanchez E, Martin L, Aguero J, Romero FP. Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats. Hepatology 1997; 25(6): (57) Dolz C, Raurich JM, Ibanez J, Obrador A, Marse P, Gaya J. Ascites increases the resting energy expenditure in liver cirrhosis. Gastroenterology 1991; 100(3): (58) Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999; 30(4): (59) Dioguardi FS. Nutritional and hemodynamic implications of large volumes paracentesis in cirrhotics. Eur Rev Med Pharmacol Sci 1997; 1(1-3): (60) Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, Hepatology 2002; 35(3): (61) Abou-Assi S, Vlahcevic ZR. Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible. Postgrad Med 2001; 109(2):52-60, 63. (62) Blei AT, Cordoba J. Hepatic Encephalopathy. Am J Gastroenterol 2001; 96(7): (63) Hawkins RA, Jessy J, Mans AM, Chedid A, DeJoseph MR. Neomycin reduces the intestinal production of ammonia from glutamine. Adv Exp Med Biol 1994; 368: (64) Norenberg MD. Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 1996; 16(3): (65) Grippon P, Le Poncin LM, Boschat M, Wang S, Faure G, Dutertre D et al. Evidence for the role of ammonia in the intracerebral transfer and metabolism of tryptophan. Hepatology 1986; 6(4): (66) Butterworth RF. The neurobiology of hepatic encephalopathy. Semin Liver Dis 1996; 16(3): (67) Stahl J. Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance. Ann Intern Med 1963; 58:1-24. (68) Lockwood AH, Yap EW, Wong WH. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991; 11(2): (69) Kramer L, Tribl B, Gendo A, Zauner C, Schneider B, Ferenci P et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology 2000; 31(1): (70) Hindfelt B, Plum F, Duffy TE. Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J Clin Invest 1977; 59(3):

3 (71) Theoret Y, Bossu JL. Effects of ammonium salts on synaptic transmission to hippocampal CA1 and CA3 pyramidal cells in vivo. Neuroscience 1985; 14(3): (72) de Knegt RJ, Schalm SW, van der Rijt CC, Fekkes D, Dalm E, Hekking-Weyma I. Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis. J Hepatol 1994; 20(1): (73) Takahashi H, Koehler RC, Brusilow SW, Traystman RJ. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 1991; 261(3 Pt 2):H825-H829. (74) Fischer JE, Funovics JM, Aguirre A, James JH, Keane JM, Wesdorp RI et al. The role of plasma amino acids in hepatic encephalopathy. Surgery 1975; 78(3): (75) Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976; 80(1): (76) Schafer DF, Jones EA. Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system. Lancet 1982; 1(8262): (77) Levy LJ, Losowsky MS. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease. Hepatogastroenterology 1989; 36(6): (78) Thompson JS, Schafer DF, Schafer GJ, Hodgson PE. gamma-aminobutyric acid plasma levels and brain binding in Eck fistula dogs. J Surg Res 1985; 38(2): (79) Blei AT. Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem. Hepatology 1991; 13(2): (80) Pardridge WM. Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem 1977; 28(1): (81) Krieger D, Krieger S, Jansen O, Gass P, Theilmann L, Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet 1995; 346(8970): (82) Rose C, Butterworth RF, Zayed J, Normandin L, Todd K, Michalak A et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117(3): (83) van der Rijt CC, Schalm SW, Schat H, Foeken K, De Jong G. Overt hepatic encephalopathy precipitated by zinc deficiency. Gastroenterology 1991; 100(4): (84) Riggio O, Ariosto F, Merli M, Caschera M, Zullo A, Balducci G et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci 1991; 36(9): (85) Read AE, Laidlaw J, Haslam RM, Sherlock S. Neuropsychiatric complications following chlorothiazide therapy in patients with hepatic cirrhosis: possible relation to hypokalaemia. Clin Sci 1959; 18: (86) Farinati F, De Bona M, Floreani A, Foschia F, Rugge M. Helicobacter pylori and the liver: any relationship? Ital J Gastroenterol Hepatol 1998; 30(1): (87) Vasconez C, Elizalde JI, Llach J, Gines A, de la RC, Fernandez RM et al. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. J Hepatol 1999; 30(2): (88) Fitz JG. Hepatic Encephalopathy, Hepatopulmonary Syndromes, Hepatorenal Syndrome, Coagulopathy, and Endocrine Complications of Liver Disease. In: Feldman M, Friedman LS, Sleisenger MH, editors. (89) Bircher J, Scollo-Lavizzari G, Hoffmann K, Haemmerli UP. [Treatment of chronic porto-systemic encephalopathy with lactulose]. Schweiz Med Wochenschr 1969; 99(16):584. (90) Clausen MR, Jorgensen J, Mortensen PB. Comparison of diarrhea induced by ingestion of fructooligosaccharide Idolax and disaccharide lactulose: role of osmolarity versus fermentation of malabsorbed carbohydrate. Dig Dis Sci 1998; 43(12): (91) Fernandes J, Morali G, Wolever TM, Blendis LM, Koo M, Jenkins DJ et al. Effect of acute lactulose administration on serum acetate levels in cirrhosis. Clin Invest Med 1994; 17(3): (92) Huchzermeyer H, Schumann C. Lactulose--a multifaceted substance. Z Gastroenterol 1997; 35(10): (93) Berk DP, Chalmers T. Deafness complicating antibiotic therapy of hepatic encephalopathy. Ann Intern Med 1970; 73(3): (94) Morgan MH, Read AE, Speller DC. Treatment of hepatic encephalopathy with metronidazole. Gut 1982; 23(1):1-7. (95) Loft S, Sonne J, Dossing M, Andreasen PB. Metronidazole pharmacokinetics in patients with hepatic encephalopathy. Scand J Gastroenterol 1987; 22(1): (96) Staedt U, Leweling H, Gladisch R, Kortsik C, Hagmuller E, Holm E. Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover design. J Hepatol 1993; 19(3): (97) Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R et al. Therapeutic efficacy of L-ornithine- L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 1997; 25(6): (98) Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Gortelmeyer R et al. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol 1998; 28(5): (99) Lochs H, Plauth M. Liver cirrhosis: rationale and modalities for nutritional support--the European Society of Parenteral and Enteral Nutrition consensus and beyond. Curr Opin Clin Nutr Metab Care 1999; 2(4): (100) Zillikens MC, van den Berg JW, Wilson JH, Swart GR. Whole-body and segmental bioelectrical-impedance analysis in patients with cirrhosis of the liver: changes after treatment of ascites. Am J Clin Nutr 1992; 55(3):

4 (101) Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH et al. Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. JPEN J Parenter Enteral Nutr 1995; 19(4): (102) Pomposelli JJ, Burns DL. Nutrition support in the liver transplant patient. Nutr Clin Pract 2002; 17: (103) Mills PR, Shenkin A, Anthony RS, McLelland AS, Main AN, MacSween RN et al. Assessment of nutritional status and in vivo immune responses in alcoholic liver disease. Am J Clin Nutr 1983; 38(6): (104) O'Keefe SJ, El Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet 1980; 2(8195 pt 1): (105) Morgan AG, Kelleher J, Walker BE, Losowsky MS. Nutrition in cryptogenic cirrhosis and chronic aggressive hepatitis. Gut 1976; 17(2): (106) Charleton MR. Branched chains revisited. Gastroenterology 1996; 111:252. (107) Roongpisuthipong C, Sobhonslidsuk A, Nantiruj K, Songchitsomboon S. Nutritional assessment in various stages of liver cirrhosis. Nutrition 2001; 17(9): (108) Morgan MY. Enteral nutrition in chronic liver disease. Acta Chir Scand Suppl 1981; 507: (109) Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology 1993; 17(4): (110) Lautz HU, Selberg O, Korber J, Burger M, Muller MJ. Protein-calorie malnutrition in liver cirrhosis. Clin Investig 1992; 70(6): (111) Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Muller MJ. ESPEN guidelines for nutrition in liver disease and transplantation. Clinical nutrition 1997; 16(2): (112) Scolapio JS, Ukleja A, McGreevy K, Burnett OL, O'Brien PC. Nutritional problems in end-stage liver disease: contribution of impaired gastric emptying and ascites. J Clin Gastroenterol 2002; 34(1): (113) Mahan LK, Escott-Stump S. Krause's Food, Nutrition, & Diet Therapy. 10 ed. London: WB Saunders Company, (114) Muller MJ, Lautz HU, Plogmann B, Burger M, Korber J, Schmidt FW. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992; 15(5): (115) Patek AJ, Post J, Ratnoff OF, Mankin H, Hillman RW. Dietary treatment of cirrhosis of the liver. JAMA 1948; 139: (116) Bianchi GP, Marchesini G, Fabbri A, Rondelli A, Bugianesi E, Zoli M et al. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison. J Intern Med 1993; 233(5): (117) Uribe M, Marquez MA, Garcia RG, Ramos-Uribe MH, Vargas F, Villalobos A et al. Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study. Dig Dis Sci 1982; 27(12): (118) Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Viteri A et al. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology 1984; 4(2): (119) Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. J Hepatol 1990; 11(1): (120) Naylor CD, O'Rourke K, Detsky AS, Baker JP. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology 1989; 97(4): (121) Fabbri A, Magrini N, Bianchi G, Zoli M, Marchesini G. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. JPEN J Parenter Enteral Nutr 1996; 20(2): (122) Fischer JE. Branched-chain-enriched amino acid solutions in patients with liver failure: an early example of nutritional pharmacology. JPEN J Parenter Enteral Nutr 1990; 14(5 Suppl):249S-256S. (123) Klein S, Kinney J, Jeejeebhoy K, Alpers D, Hellerstein M, Murray M et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. JPEN J Parenter Enteral Nutr 1997; 21(3): (124) Morgan MH, Bolton CH, Morris JS, Read AE. Medium chain triglycerides and hepatic encephalopathy. Gut 1974; 15(3): (125) Muscaritoli M, Cangiano C, Cascino A, Ceci F, Caputo V, Martino P et al. Exogenous lipid clearance in compensated liver cirrhosis. JPEN J Parenter Enteral Nutr 1986; 10(6): (126) Fischer GW, Hunter KW, Wilson SR, Mease AD. Diminished bacterial defences with intralipid. Lancet 1980; 2(8199): (127) Muller JM, Keller HW, Brenner U, Walter M, Holzmuller W. Indications and effects of preoperative parenteral nutrition. World J Surg 1986; 10(1): (128) Negro F, Cerra FB. Nutritional monitoring in the ICU: rational and practical application. Crit Care Clin 1988; 4(3): (129) Chang N, Kim E, Kim SY, Jeong BS. Study of the relation between proton magnetic resonance spectroscopy metabolites in the brain regions and the B vitamin status in alcoholics. Nutrition Research 2001; 21(6): (130) Leevy CM, Thompson A, Baker H. Vitamins and liver injury. Am J Clin Nutr 1970; 23(4): (131) McClain CJ, Marsano L, Burk RF, Bacon B. Trace metals in liver disease. Semin Liver Dis 1991; 11(4): (132) Riggio O, Merli M, Capocaccia L, Caschera M, Zullo A, Pinto G et al. Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis. Hepatology 1992; 16(3): (133) Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337(7): (134) Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology 1996; 23(5):

5 (135) Bianchi GP, Marchesini G, Brizi M, Rossi B, Forlani G, Boni P et al. Nutritional effects of oral zinc supplementation in cirrhosis. Nutrition Research 2000; 20(8): (136) Isobe H, Sakai H, Satoh M, Sakamoto S, Nawata H. Delayed gastric emptying in patients with liver cirrhosis. Dig Dis Sci 1994; 39(5): (137) Kearns PJ, Young H, Garcia G, Blaschke T, O'Hanlon G, Rinki M et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992; 102(1): (138) De L, V, Beau P, Mannant PR, Borderie C, Ripault MP, Silvain C et al. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Dig Dis Sci 1997; 42(3): (139) Marchesini G, Zoli M, Dondi C, Bianchi G, Cirulli M, Pisi E. Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology 1982; 2(4): (140) Shaw BW, Jr., Wood RP, Gordon RD, Iwatsuki S, Gillquist WP, Starzl TE. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985; 5(4): (141) Reilly J, Mehta R, Teperman L, Cemaj S, Tzakis A, Yanaga K et al. Nutritional support after liver transplantation: a randomized prospective study. JPEN J Parenter Enteral Nutr 1990; 14(4): (142) Wicks C, Bray G, Williams R. Nutritional assessment in primary biliary cirrhosis. The effect of disease progression. Clin Nutr 1995; 14: (143) Weimann A, Kuse ER, Bechstein WO, Neuberger JM, Plauth M, Pichlmayr R. Perioperative parenteral and enteral nutrition for patients undergoing orthotopic liver transplantation. Results of a questionnaire from 16 European transplant units. Transpl Int 1998; 11 Suppl 1:S289-S291. (144) Chin SE, Shepherd RW, Thomas BJ, Cleghorn GJ, Patrick MK, Wilcox JA et al. Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr 1992; 56(1): (145) Oates JA, Wood AJJ. Cyclosporine. N Engl J Med 1989; 321: (146) Brown SA, Goringe A, Fegan C, Davies SV, Giddings J, Whittaker JA et al. Parenteral glutamine protects hepatic function during bone marrow transplantation. Bone Marrow Transplant 1998; 22(3): (147) Cabre E, Gonzalez-Huix F, Abad-Lacruz A, Esteve M, Acero D, Fernandez-Banares F et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990; 98(3): (148) Ichida T, Shibasaki K, Muto Y, Satoh S, Watanabe A, Ichida F. Clinical study of an enteral branched-chain amino acid solution in decompensated liver cirrhosis with hepatic encephalopathy. Nutrition 1995; 11(2 Suppl): (149) Tangkijvanich P, Mahachai V, Wittayalertpanya S, Ariyawongsopon V, Isarasena S. Short-term effects of branched-chain amino acids on liver function tests in cirrhotic patients. Southeast Asian J Trop Med Public Health 2000; 31(1): (150) Meng WC, Leung KL, Ho RL, Leung TW, Lau WY. Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma. Aust N Z J Surg 1999; 69(11): (151) Mezey E, Caballeria J, Mitchell MC, Pares A, Herlong HF, Rodes J. Effect of parenteral amino acid supplementation on short-term and long-term outcomes in severe alcoholic hepatitis: a randomized controlled trial. Hepatology 1991; 14(6): (152) Hirsch S, Bunout D, de la MP, Iturriaga H, Petermann M, Icazar G et al. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. JPEN J Parenter Enteral Nutr 1993; 17(2): (153) Bonkovsky HL, Fiellin DA, Smith GS, Slaker DP, Simon D, Galambos JT. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. Am J Gastroenterol 1991; 86(9): (154) Bonkovsky HL, Singh RH, Jafri IH, Fiellin DA, Smith GS, Simon D et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. II. Short-term effects on nitrogen metabolism, metabolic balance, and nutrition. Am J Gastroenterol 1991; 86(9):

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957

More information

Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial

Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial Marcus R. Pereira A. Study Purpose Hepatic encephalopathy is a common complication

More information

Economic Impact of Treatment Options for Hepatic Encephalopathy

Economic Impact of Treatment Options for Hepatic Encephalopathy Economic Impact of Treatment Options for Hepatic Encephalopathy Carroll B. Leevy, M.D. 1 ABSTRACT Complications of chronic liver disease, such as hepatic encephalopathy (HE), can have a substantial impact

More information

Precipitating Factors of Hepatic Encephalopathy

Precipitating Factors of Hepatic Encephalopathy Original Article Precipitating Factors of Hepatic Encephalopathy Mohammad Tariq,* Saleem Iqbal,** Naji ullah Khan,* Rabia Basri*** From Department of Medicine, Khyber Teaching Hospital, Peshawar. *Post

More information

Hepatic Encephalopathy, Hyperammonemia, and Current Treatment in ICU Room

Hepatic Encephalopathy, Hyperammonemia, and Current Treatment in ICU Room Hepatic Encephalopathy, Hyperammonemia, and Current Treatment in ICU Room Assoc.Prof. Chan Sovandy Chairman by : Prof.So Saphy and Assoc Prof, Kim chhoung Hepatic Encephalopathy Hepatic (portal systemic

More information

DIETARY THERAPY IMPACT FOR CIRRHOTIC PATIENTS WITH HEPATIC ENCEPHALOPATHY

DIETARY THERAPY IMPACT FOR CIRRHOTIC PATIENTS WITH HEPATIC ENCEPHALOPATHY ORIGINAL PAPER 373 DIETARY THERAPY IMPACT FOR CIRRHOTIC PATIENTS WITH HEPATIC ENCEPHALOPATHY Adriana Teiuşanu 1,, Mirela Ionescu 1, S. Gologan 1, Adriana Stoicescu 1, M. Andrei 1, T. Nicolaie 1, M. Diculescu

More information

The pathogenesis of hepatic encephalopathy in

The pathogenesis of hepatic encephalopathy in Correlation between Ammonia Levels and the Severity of Hepatic Encephalopathy Janus P. Ong, MD, Anjana Aggarwal, MD, Derk Krieger, MD, Kirk A. Easley, MS, Matthew T. Karafa, MS, Frederick Van Lente, PhD,

More information

Evaluation and Prognosis of Patients with Cirrhosis

Evaluation and Prognosis of Patients with Cirrhosis Evaluation and Prognosis of Patients with Cirrhosis Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded

More information

HEPATIC ENCEPHALOPATHY; PRECIPITATING FACTORS IN PATIENTS WITH CIRRHOSIS

HEPATIC ENCEPHALOPATHY; PRECIPITATING FACTORS IN PATIENTS WITH CIRRHOSIS HEPATIC ENCEPHALOPATHY 375 ORIGINAL PROF-335 HEPATIC ENCEPHALOPATHY; PRECIPITATING FACTORS IN PATIENTS WITH CIRRHOSIS COL. DR. MANZAR ZAKARIA Classified Medical Specialist Department of Medicine DR. SYED

More information

The sooner the better

The sooner the better The sooner the better A guide to MARS the liver support therapy Liver failure and MARS therapy Developing acute liver failure or deteriorating from a chronic liver disease, thousands of people are enlisted

More information

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient

More information

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis Research Article Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis RR. Pawar*, ML. Pardeshi and BB. Ghongane Department of Pharmacology, B.J. Medical

More information

Liver, Gallbladder, Exocrine Pancreas KNH 406

Liver, Gallbladder, Exocrine Pancreas KNH 406 Liver, Gallbladder, Exocrine Pancreas KNH 406 2007 Thomson - Wadsworth LIVER Anatomy - functions With disease blood flow becomes obstructed Bile All bile drains into common hepatic duct Liver Bile complex

More information

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH Professor of Medicine Department of Gastroenterology Director, Viral Hepatitis Center University of California San Francisco

More information

NUTRITION IN LIVER DISEASES

NUTRITION IN LIVER DISEASES NUTRITION IN LIVER DISEASES 1. HEPATITIS: Definition: - Viral inflammation of liver cells. Types: a. HAV& HEV, transmitted by fecal-oral route. b. HBV & HCV, transmitted by blood and body fluids. c. HDV

More information

Nutrition in Liver Disease

Nutrition in Liver Disease Nutrition in Liver Disease Mathias Plauth Klinik für Innere Medizin Städtisches Klinikum Dessau Nestlé 10 th Clinical Nutrition Course June 5-10, 2011, Lausanne, Switzerland Malnutrition in Cirrhosis?

More information

23/06/2014. Nutrition in Chronic Liver Disease. Objectives. Question #1

23/06/2014. Nutrition in Chronic Liver Disease. Objectives. Question #1 Nutrition in Chronic Liver Disease Maitreyi Raman, MD, FRCPC Clinical Associate Professor University of Calgary April 2014 Objectives 1. Describe contributing factors toward malnutrition in advanced liver

More information

HEPATIC ENCEPHALOPATHY

HEPATIC ENCEPHALOPATHY HEPATIC ENCEPHALOPATHY Jan Albrecht Department of Neurotoxicology, Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland Brussels, July 14, 2009 DEFINITIONS: - HEPATIC ENCEPHALOPATHY (HE)

More information

MANAGEMENT OF LIVER CIRRHOSIS

MANAGEMENT OF LIVER CIRRHOSIS MANAGEMENT OF LIVER CIRRHOSIS Information Leaflet Your Health. Our Priority. Page 2 of 6 What is cirrhosis? Cirrhosis is a result of long-term, continuous damage to the liver and may be due to many different

More information

THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES. Key Points

THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES. Key Points December 2008 (Vol. 1, Issue 3, pages 36-40) THE ENDOCANNABINOID SYSTEM AS A THERAPEUTIC TARGET FOR LIVER DISEASES By Sophie Lotersztajn, PhD, Ariane Mallat, MD, PhD Inserm U841, Hôpital Henri Mondor,

More information

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Brochure More information from http://www.researchandmarkets.com/reports/1047385/ Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Description: Liver disease is a rapidly growing

More information

Date of preparation: March 2015. GL/XIF/0214/0011a(1)

Date of preparation: March 2015. GL/XIF/0214/0011a(1) Date of preparation: March 2015. GL/XIF/0214/0011a(1) 1 This educational programme is funded by a grant from Norgine. Norgine has no involvement in the development of the content, which is developed independently

More information

Liver Failure. Nora Aziz. www.3bv.org. Bones, Brains & Blood Vessels

Liver Failure. Nora Aziz. www.3bv.org. Bones, Brains & Blood Vessels Liver Failure Nora Aziz www.3bv.org Bones, Brains & Blood Vessels Severe deterioration in liver function Looses ability to regenerate/repair decompensated Liver extensively damaged before it fails Equal

More information

Hepatic Encephalopathy

Hepatic Encephalopathy THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 96, No. 7, 2001 2001 by Am. Coll. of Gastroenterology ISSN 0002-9270/01/$20.00 Published by Elsevier Science Inc. PII S0002-9270(01)02527-8 PRACTICE GUIDELINES

More information

Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care

Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care Primary Care Guidance Program: Non-Alcohol related Fatty Liver Disease (NAFLD) Guidance on Management in Primary Care This advice has been developed to help GPs with shared care of patients with Non- Alcohol

More information

Nutritional support in the treatment of chronic hepatic encephalopathy

Nutritional support in the treatment of chronic hepatic encephalopathy MODULE? Vol. 10 Suppl.2, 2011: S45-S49 S45 Nutritional support in the treatment of chronic hepatic encephalopathy María del Pilar Milke García* * Instituto Nacional de Ciencias Médicas y Nutrición Salvador

More information

Management of Spontaneous Rupture of Liver Tumours

Management of Spontaneous Rupture of Liver Tumours Complications in Hepatobiliary Surgery Dig Surg 2002;19:109 113 P. Marini a V. Vilgrain b J. Belghiti a Departments of a Hepatopancreatobiliary Surgery and b Radiology, Beaujon Hospital, Assistance Publique,

More information

Severe Acute Hepatic Encephalopathy in Cirrhotic patients: The gut remains an important target of therapy

Severe Acute Hepatic Encephalopathy in Cirrhotic patients: The gut remains an important target of therapy Severe Acute Hepatic Encephalopathy in Cirrhotic patients: The gut remains an important target of therapy Rohit Sawhney, Rajiv Jalan Liver Failure Group, Institute for Liver and Digestive Health, University

More information

Cirrhosis and HCV. Jonathan Israel M.D.

Cirrhosis and HCV. Jonathan Israel M.D. Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment

More information

Role of Branched Chain Amino Acids in the Management of Hepatic Encephalopathy

Role of Branched Chain Amino Acids in the Management of Hepatic Encephalopathy World Journal of Medical Sciences 3 (2): 60-64, 2008 ISSN 1817-3055 IDOSI Publications, 2008 Role of Branched Chain Amino Acids in e Management of Hepatic Encephalopay 1 1 1 1 2 Aftab Ahmed Soomro, Bikha

More information

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common

More information

EVALUATION OF PROGNOSTIC FACTORS IN DECOMPENSATED LIVER CIRRHOSIS WITH ASCITES AND SPONTANEOUS BACTERIAL PERITONITIS

EVALUATION OF PROGNOSTIC FACTORS IN DECOMPENSATED LIVER CIRRHOSIS WITH ASCITES AND SPONTANEOUS BACTERIAL PERITONITIS Rev. Med. Chir. Soc. Med. Nat., Iaşi 2015 vol. 119, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS EVALUATION OF PROGNOSTIC FACTORS IN DECOMPENSATED LIVER CIRRHOSIS WITH ASCITES AND SPONTANEOUS BACTERIAL

More information

NUTB 316 ADVANCED MEDICAL NUTRITION THERAPY MNSP Tufts University, Friedman School of Nutrition Science and Policy

NUTB 316 ADVANCED MEDICAL NUTRITION THERAPY MNSP Tufts University, Friedman School of Nutrition Science and Policy NUTB 316 ADVANCED MEDICAL NUTRITION THERAPY MNSP Tufts University, Friedman School of Nutrition Science and Policy SUMMER 2015 (May 20, 2015 - August 16, 2015) Instructors: Kathy Prelack, PhD, RD kprelack@tufts.edu

More information

June 11, 2015 Tim Halterman

June 11, 2015 Tim Halterman June 11, 2015 Tim Halterman Defini&on Histologic change + loss of liver function Derives from Greek word kirrhos meaning yellow, tawny First named by Rene Laennec in 1819 Laennec s cirrhosis=alcoholic

More information

Clinical trial: oral zinc in hepatic encephalopathy

Clinical trial: oral zinc in hepatic encephalopathy Alimentary Pharmacology and Therapeutics Clinical trial: oral zinc in hepatic encephalopathy Y. Takuma*,, K. Nouso à, Y. Makino, M. Hayashi & H. Takahashi *Department of Gastroenterology, Kurashiki Central

More information

ABSTRACT INTRODUCTION. Roxana Irimia 1, Carol Stanciu 2, Camelia Cojocariu 1,2, Cătălin Sfarti 1,2, Anca Trifan 1,2

ABSTRACT INTRODUCTION. Roxana Irimia 1, Carol Stanciu 2, Camelia Cojocariu 1,2, Cătălin Sfarti 1,2, Anca Trifan 1,2 Oral Glutamine Challenge Improves the Performance of Psychometric Tests for the Diagnosis of Minimal Hepatic Encephalopathy in Patients with Liver Cirrhosis Roxana Irimia 1, Carol Stanciu 2, Camelia Cojocariu

More information

Non-alcoholic fatty liver disease: Prognosis and Treatment

Non-alcoholic fatty liver disease: Prognosis and Treatment Non-alcoholic fatty liver disease: Prognosis and Treatment Zachary Henry, M.D. Assistant Professor UVA Gastroenterology & Hepatology October 28, 2015 Overview Case Presentation Prognosis Effects of fibrosis

More information

BURDEN OF LIVER DISEASE IN BRAZIL

BURDEN OF LIVER DISEASE IN BRAZIL BURDEN OF LIVER DISEASE IN BRAZIL Burden of Liver Disease in Europe Blachier et al. J Hepatol 58:593, 2013 Review of 260 epidemiologic studies of the 5 previous years Cirrhosis is responsible for 170.000

More information

COMPLICATIONS OF CIRRHOSIS COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST. Philip C. Delich, M.D.

COMPLICATIONS OF CIRRHOSIS COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST. Philip C. Delich, M.D. 1 COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST COMPLICATIONS OF CIRRHOSIS Philip C. Delich, M.D. Faculty Disclosure Dr. Delich has indicated that he does not have any relevant financial

More information

GASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo

GASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo GASTROENTEROLOGY FELLOWSHIP HEPATOLOGY ROTATION GOALS AND OBJECTIVES University of Toledo Educational Purpose: The Hepatology Rotation introduces the fellow to the management of outpatients and inpatients

More information

Current Concepts. Review Article T REATMENT OF HEPATIC ENCEPHALOPATHY

Current Concepts. Review Article T REATMENT OF HEPATIC ENCEPHALOPATHY C U R R E N T C O N C E P T S Review Article Current Concepts T REATMENT OF HEPATIC ENCEPHALOPATHY STEPHEN M. RIORDAN, M.D., AND ROGER WILLIAMS, M.D. HEPATIC encephalopathy is a complex neuropsychiatric

More information

HEPATOLOGY CLERKSHIP

HEPATOLOGY CLERKSHIP College of Osteopathic Medicine HEPATOLOGY CLERKSHIP Office for Clinical Affairs 515-271-1629 FAX 515-271-1727 Elective Rotation General Description This elective rotation is a four (4) week introductory,

More information

edigraphic.com Otras secciones de este sitio: Others sections in this web site: Contents of this number More journals Search

edigraphic.com Otras secciones de este sitio: Others sections in this web site: Contents of this number More journals Search ANNALS OF HEPATOLOGY Volume 2 Number 3 July - September 2003 Artículo: Hepatic encephalopathy: A review Copyright 2003: Mexican Association of Hepatology Otras secciones de este sitio: Índice de este número

More information

Dose-Response Effects of Sodium Intake on Blood Pressure

Dose-Response Effects of Sodium Intake on Blood Pressure I Dose-Response Effects of Sodium Intake on 1 +2 NS +1 NS -2 NS +5 NS 0.46 (20) 4.6 () 25.9 (1128) FIGURE I-1 Blood pressure (mm Hg) according to dietary sodium intake in g/d (mmol/d) among 8 normotensive

More information

ESPEN guidelines for nutrition in liver disease and transplantation

ESPEN guidelines for nutrition in liver disease and transplantation Clinical Nutrition (1997) 16:43-55 Pearson Professional Ltd 1997 CONSENSUS STATEMENT ESPEN guidelines for nutrition in liver disease and transplantation M. PLAUTH, M. MERLI, J. KONDRUP, A. WEIMANN, P.

More information

Hepatitis C Glossary of Terms

Hepatitis C Glossary of Terms Acute Hepatitis C A short-term illness that usually occurs within the first six months after someone is exposed to the hepatitis C virus (HCV). 1 Antibodies Proteins produced as part of the body s immune

More information

{ Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta Analysis}

{ Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta Analysis} { Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta Analysis} {Dong Wu, Shu-Mei Wu, Jie Lu, Ying-Qun Zhou, Ling Xu, and Chuan-Yong Guo} Noor Al-Hakami, Pharm

More information

A Problem-Based Learning Approach to Incorporating Nutrition into the Medical Curriculum

A Problem-Based Learning Approach to Incorporating Nutrition into the Medical Curriculum A Problem-Based Learning Approach to Incorporating Nutrition into the Medical Curriculum Marilyn S. Edwards, Ph.D., R.D. * and Gary C. Rosenfeld, Ph.D. * Department of Internal Medicine and Department

More information

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9 Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer

More information

PIERO LUIGI ALMASIO CATTEDRA DI GASTROENTEROLOGIA UNIVERSITA OF PALERMO

PIERO LUIGI ALMASIO CATTEDRA DI GASTROENTEROLOGIA UNIVERSITA OF PALERMO Steatosi e Steatoepatite PIERO LUIGI ALMASIO CATTEDRA DI GASTROENTEROLOGIA UNIVERSITA OF PALERMO Alcoholic liver disease Liver damage resulting from long-term alcohol consumption Histological features:

More information

Acute on Chronic Liver Failure: Current Concepts. Disclosures

Acute on Chronic Liver Failure: Current Concepts. Disclosures Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures

More information

Surveillance for Hepatocellular Carcinoma

Surveillance for Hepatocellular Carcinoma Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April

More information

Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases

Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases Subproject 4: Specification and Documentation of Metabolic and Neoplastic Diseases M. Trauner, Division of Gastroenterology and Hepatology, Department of Internal Medicine, MUG Co- Investigator: H. Samonigg,

More information

a series of fact sheets written by experts in the field of liver disease HCV DISEASE PROGRESSION

a series of fact sheets written by experts in the field of liver disease HCV DISEASE PROGRESSION www.hcvadvocate.org HCSP FACT SHEET Symptoms & Complications of Cirrhosis Foreword After many years of infection with hepatitis C the liver can become severely scarred. The process starts with inflammation

More information

Clinical Nutrition 28 (2009) 436 444. Contents lists available at ScienceDirect. Clinical Nutrition

Clinical Nutrition 28 (2009) 436 444. Contents lists available at ScienceDirect. Clinical Nutrition Clinical Nutrition 28 (2009) 436 444 Contents lists available at ScienceDirect Clinical Nutrition journal homepage: http://www.elsevier.com/locate/clnu ESPEN Guidelines on Parenteral Nutrition: Hepatology

More information

Patterns of abnormal LFTs and their differential diagnosis

Patterns of abnormal LFTs and their differential diagnosis Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function

More information

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

BACKGROUND MEDIA INFORMATION Fast facts about liver disease BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of

More information

NUTRITION OF THE BODY

NUTRITION OF THE BODY 5 Training Objectives:! Knowledge of the most important function of nutrients! Description of both, mechanism and function of gluconeogenesis! Knowledge of the difference between essential and conditionally

More information

Albumin (serum, plasma)

Albumin (serum, plasma) Albumin (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Albumin (plasma or serum) 1.2 Alternative names None (note that albumen is a protein found in avian eggs) 1.3 NLMC code 1.4

More information

Nurse Practitioner Outcomes: The Integration & Future Directions of The Liver Transplant NP. Amanda Tinning MN NP October 13, 2011

Nurse Practitioner Outcomes: The Integration & Future Directions of The Liver Transplant NP. Amanda Tinning MN NP October 13, 2011 Nurse Practitioner Outcomes: The Integration & Future Directions of The Liver Transplant NP Amanda Tinning MN NP October 13, 2011 Overview Define clinical outcomes Discuss the contributions of the NP role

More information

LIVER TRANSPLANTATION IN ALAGILLE SYNDROME

LIVER TRANSPLANTATION IN ALAGILLE SYNDROME LIVER TRANSPLANTATION IN ALAGILLE SYNDROME Ronald J. Sokol, MD Children s Hospital Colorado University of Colorado School of Medicine Treatment of Liver Disease in Improve bile flow ALGS Ursodeoxycholic

More information

Indications in Hepatology and Liver Diseases

Indications in Hepatology and Liver Diseases exclusively working in Health Care sananet GmbH Tilo Stolzke Breite Str. 6-8 23562 Lübeck Germany Telefon : +49 451 400 8301 Telefax : +49 451 400 8302 E-Mail : stolzke@sananet.com Internet : www.sananet.com

More information

190.33 - Hepatitis Panel/Acute Hepatitis Panel

190.33 - Hepatitis Panel/Acute Hepatitis Panel 190.33 - Hepatitis Panel/Acute Hepatitis Panel This panel consists of the following tests: Hepatitis A antibody (HAAb), IgM antibody; Hepatitis B core antibody (HBcAb), IgM antibody; Hepatitis B surface

More information

DIET AND NUTRITION FOR LIVER DISEASE AND HEPATITIS. By Dr. Hassan El Shennawy Prof. of medicine National Liver Institute Menoufya Universty

DIET AND NUTRITION FOR LIVER DISEASE AND HEPATITIS. By Dr. Hassan El Shennawy Prof. of medicine National Liver Institute Menoufya Universty DIET AND NUTRITION FOR LIVER DISEASE AND HEPATITIS By Dr. Hassan El Shennawy Prof. of medicine National Liver Institute Menoufya Universty Contents : Introduction DIET IN ACUTE LIVER DISEASE DIET IN CHRONIC

More information

A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy

A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy Chavez-Tapia et al. Nutrition Journal 2013, 12:74 REVIEW Open Access A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy Norberto C Chavez-Tapia 1*,

More information

Vol. 11, No.2, pp. 159-164, Feb., 1990 (Copyright ~ 1990 the American Association for the Study of Liver Diseases) (Printed in the U.S.A.!

Vol. 11, No.2, pp. 159-164, Feb., 1990 (Copyright ~ 1990 the American Association for the Study of Liver Diseases) (Printed in the U.S.A.! ORTHOTOPIC LIVER TRANSPLANTATION FOR ALCOHOLIC LIVER DISEASE SHASHI KUMAR, RUDOLF E. STAUBER, JUDITH S. GAVALER, MICHAEL H. BASISTA, VINCENTS J. DINDZANS, ROBERT R. SCHADE, MORDECHAI RABINOVITZ, RALPH

More information

NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #95. Hepatic Encephalopathy: Are NH 4 Levels and Protein Restriction Obsolete?

NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #95. Hepatic Encephalopathy: Are NH 4 Levels and Protein Restriction Obsolete? Carol Rees Parrish, R.D., M.S., Series Editor Hepatic Encephalopathy: Are NH 4 Levels and Protein Restriction Obsolete? Peter Caruana Neeral Shah Measurement of plasma ammonia and restriction of dietary

More information

End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012

End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012 End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012 Natural History of ESLD Increasing liver fibrosis Development of HCC Chronic liver disease Compensated cirrhosis Decompensated cirrhosis

More information

Refeeding syndrome in anorexia nervosa

Refeeding syndrome in anorexia nervosa ESPEN Congress Barcelona 2012 Is there a role for nutrition in psychiatric disorders? Refeeding syndrome in anorexia nervosa V. Haas (Germany) ESPEN - 2012 - Barcelona The refeeding syndrome in Anorexia

More information

Nutrition management in liver diseases

Nutrition management in liver diseases Nutrition management in liver diseases Assist Profess Supawan Buranapin, MD Section of Endocrinology, Department of medicine Faculty of Medicine, Chiang Mai University 9 Feb 2012 The main functions of

More information

SINPE trial, Ann Surg 2009. Overall morbidity. Minor Major. Infectious Non infectious. Post-hoc analysis WL < %5 (n=379) WL between 5-10% (n=49)

SINPE trial, Ann Surg 2009. Overall morbidity. Minor Major. Infectious Non infectious. Post-hoc analysis WL < %5 (n=379) WL between 5-10% (n=49) Chinese International Symposium on Nutritional Oncology Changchun, June 20-21 2014 IMMUNONUTRITION IN CANCER PATIENTS IMMUNONUTRITION IN SURGERY OBJECTIVE To get the patient undergoing major surgery for

More information

Malnutrition and nutrition support in patients with liver disease

Malnutrition and nutrition support in patients with liver disease Malnutrition and nutrition support in patients with liver disease John Saunders, 1 Anna Brian, 2 Mark Wright, 2 Mike Stroud 3 1 Department of Gastroenterology, Southampton University Hospital Trust, Southampton,

More information

NASH: It is not JUST a Fatty Liver. Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center

NASH: It is not JUST a Fatty Liver. Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center NASH: It is not JUST a Fatty Liver Karen F. Murray, M.D. Director of Hepatobiliary Program Children s Hospital and Regional Medical Center Stages of Fatty Liver Disorders Fatty Liver 16-35% of Western

More information

The Science of Muscle Growth and Repair By William Cabot M.D., FAAOS

The Science of Muscle Growth and Repair By William Cabot M.D., FAAOS The Science of Muscle Growth and Repair By William Cabot M.D., FAAOS Part 2 - The Role Individual Amino Acids Play in Muscle growth and Repair American Casein Company has been a worldwide leader in supplying

More information

The State of the Liver in the Adult Patient after Fontan Palliation

The State of the Liver in the Adult Patient after Fontan Palliation The State of the Liver in the Adult Patient after Fontan Palliation Fred Wu, M.D. Boston Adult Congenital Heart Service Boston Children s Hospital/Brigham & Women s Hospital 7 th National Adult Congenital

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. This online publication has been corrected. The corrected

More information

Alcoholic Liver Disease and Its Relationship with Metabolic Syndrome

Alcoholic Liver Disease and Its Relationship with Metabolic Syndrome Research and Reviews Alcoholic Liver Disease and Its Relationship with Metabolic Syndrome JMAJ 53(4): 236 242, 2010 Hiromasa ISHII,* 1 Yoshinori HORIE,* 2 Yoshiyuki YAMAGISHI,* 3 Hirotoshi EBINUMA* 3 Abstract

More information

The Primary Prevention of Type 2 Diabetes AADE Practice Synopsis Issued December 1, 2014

The Primary Prevention of Type 2 Diabetes AADE Practice Synopsis Issued December 1, 2014 Introduction The Primary Prevention of Type 2 Diabetes AADE Practice Synopsis Issued December 1, 2014 The prevalence of type 2 diabetes is reaching epidemic proportions with more than 9.3% of adults in

More information

LIVER CANCER AND TUMOURS

LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS LIVER CANCER AND TUMOURS Healthy Liver Cirrhotic Liver Tumour What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood

More information

National Digestive Diseases Information Clearinghouse

National Digestive Diseases Information Clearinghouse Cirrhosis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is cirrhosis? Cirrhosis is a condition in which the liver

More information

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB Liver Function Tests Dr Stephen Butler Paediatric Advance Trainee TDHB Introduction Case presentation What is the liver? Overview of tests used to measure liver function RJ 10 month old European girl

More information

BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY

BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY BSc in Medical Sciences with GASTROENTEROLOGY AND HEPATOLOGY Introduction The BSc in Gastroenterology and Hepatology allows a science-based study of the physiology, cell biology, pathology and pharmacology

More information

Complications of Chronic Liver Disease

Complications of Chronic Liver Disease Complications of Chronic Liver Disease By Rima A. Mohammad, Pharm.D., BCPS Reviewed by Paulina Deming, Pharm.D.; Marisel Segarra-Newnham, Pharm.D., MPH, FCCP, BCPS; and Kelly S. Bobo, Pharm.D., BCPS Learning

More information

B I N G O B I N G O. Hf Cd Na Nb Lr. I Fl Fr Mo Si. Ho Bi Ce Eu Ac. Md Co P Pa Tc. Uut Rh K N. Sb At Md H. Bh Cm H Bi Es. Mo Uus Lu P F.

B I N G O B I N G O. Hf Cd Na Nb Lr. I Fl Fr Mo Si. Ho Bi Ce Eu Ac. Md Co P Pa Tc. Uut Rh K N. Sb At Md H. Bh Cm H Bi Es. Mo Uus Lu P F. Hf Cd Na Nb Lr Ho Bi Ce u Ac I Fl Fr Mo i Md Co P Pa Tc Uut Rh K N Dy Cl N Am b At Md H Y Bh Cm H Bi s Mo Uus Lu P F Cu Ar Ag Mg K Thomas Jefferson National Accelerator Facility - Office of cience ducation

More information

Treatment of Acute Hepatitis C

Treatment of Acute Hepatitis C Management of Patients with Viral Hepatitis, Paris, 2004 Treatment of Acute Hepatitis C Michael P. Manns, Andrej Potthoff, Elmar Jaeckel, Heiner Wedemeyer Hepatitis C Virus (HCV) infection is a common

More information

Effects of hypoglycemia on brain. Ji Hyun Kim Department of Neurology Korea University College of Medicine

Effects of hypoglycemia on brain. Ji Hyun Kim Department of Neurology Korea University College of Medicine Effects of hypoglycemia on brain Ji Hyun Kim Department of Neurology Korea University College of Medicine Glucose and brain The brain is dependent on glucose as its principal fuel Interruption of glucose

More information

Hepatic encephalopathy: Suspect it early in patients with cirrhosis

Hepatic encephalopathy: Suspect it early in patients with cirrhosis REVIEW CME CREDIT EDUCATIONAL OBJECTIVE: Readers will be alert for hepatic encephalopathy early in the course of cirrhosis JamilÉ Wakim-Fleming, MD, FACG Department of Gastroenterology, Digestive Disease

More information

understanding CIRRHOSIS of the liver A patient s guide from your doctor and

understanding CIRRHOSIS of the liver A patient s guide from your doctor and understanding CIRRHOSIS of the liver A patient s guide from your doctor and Cirrhosis Basics The liver is one of the most important organs in your body and weighs about 3 pounds. It sits in the upper right

More information

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* 71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the

More information

Cardiac Cirrhosis. Presented by 高 毓 佳 2003.6.16

Cardiac Cirrhosis. Presented by 高 毓 佳 2003.6.16 Cardiac Cirrhosis Presented by 高 毓 佳 2003.6.16 Associated Cardiac and Hepatic Disorders Heart disease affecting the liver Mild alterations of liver function test in heart failure Cardiogenic ischemic hepatitis

More information

Spectrum of Precipitating factors of Hepatic Encephalopathy in liver cirrhosis

Spectrum of Precipitating factors of Hepatic Encephalopathy in liver cirrhosis Pakistan J. Med. Res. Vol. 44, No. 2, 2005 Spectrum of Precipitating factors of Hepatic Encephalopathy in liver cirrhosis Intekhab Alam, Razaullah, Iqbal Haider, M Humayun, M Amjad Taqweem, Muhammad Nisar

More information

Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr

Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Vitamin D und seine Bedeutung im Immunsystem und bei der Infektabwehr Stefan Pilz Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria Department

More information

Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment. the diagnosis and evaluation of cirrhosis

Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment. the diagnosis and evaluation of cirrhosis Cirrhosis and Chronic Liver Failure: Part II. Complications and Treatment JOEL J. HEIDELBAUGH, M.D., and MARYANN SHERBONDY, M.D. University of Michigan Medical School, Ann Arbor, Michigan Major complications

More information

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto PREVENTION OF HCC BY HEPATITIS C TREATMENT Morris Sherman University of Toronto Pathogenesis of HCC in chronic hepatitis C Injury cirrhosis HCC Injury cirrhosis HCC Time The Ideal Study Prospective randomized

More information

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s! How to Interpret and Use Them René Romero, M.D. Clinical Director, Pediatric Hepatology CPG Gastroenterology, Hepatology and Nutrition Emory University School of Medicine Objectives Understand the anatomy

More information

NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #6. Nutrition for Patients with Hepatic Failure

NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #6. Nutrition for Patients with Hepatic Failure Series Editor: Carol Rees Parrish, M.S., R.D., CNSD Nutrition for Patients with Hepatic Failure Joseph Krenitsky Malnutrition is prevalent in patients with hepatic failure; it is also an independent risk

More information

Overview. Nutritional Aspects of Primary Biliary Cirrhosis. How does the liver affect nutritional status?

Overview. Nutritional Aspects of Primary Biliary Cirrhosis. How does the liver affect nutritional status? Overview Nutritional Aspects of Primary Biliary Cirrhosis Tracy Burch, RD, CNSD Kovler Organ Transplant Center Northwestern Memorial Hospital Importance of nutrition therapy in PBC Incidence and pertinence

More information

A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY

A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY 2 1 Mr N.N. 56 yr old male. Admitted on 22/03/02. 1 month Hx of abdominal distention, confusion, inability to concentrate and dyspnoea Grade 111. Pmx:

More information

LU:research Institutional Repository of Lund University

LU:research Institutional Repository of Lund University LU:research Institutional Repository of Lund University This is an author produced version of a paper published in Journal of clinical gastroenterology. This paper has been peer-reviewed but does not include

More information

ESPEN guidelines in cystic fibrosis

ESPEN guidelines in cystic fibrosis ESPEN Congress Barcelona 2012 Achieving goals by guidelines: myth or reality? ESPEN guidelines in cystic fibrosis D. Turck (France) Guidelines on the nutritional support in cystic fibrosis WG D Turck (Lille,

More information